Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Clinical trial NCT01827371 · COMPLETED
Trial details
- NCT number
- NCT01827371
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2015-04-01
- Enrollment
- 435
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.